
Aziza T Shad MD
Professor, Pediatrics, Georgetown University School of Medicine
Join to View Full Profile
3800 Reservoir Rd NWWashington, DC 20007
Phone+1 202-444-7599
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Aziza Shad, MD is a pediatric hematologist/oncologist in Washington, District of Columbia. She is currently licensed to practice medicine in District of Columbia, Maryland, and Pennsylvania. She is a Professor at Georgetown University School of Medicine.
Education & Training
- Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1986 - 1989
- Dow University of Health SciencesClass of 1977
Certifications & Licensure
- DC State Medical License 1995 - 2027
- MD State Medical License 2007 - 2025
- PA State Medical License 1988 - 1998
- WA State Medical License 1985 - 1988
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 1 citationsChildhood cancer presentation and initial outcomes in Ethiopia: Findings from a recently opened pediatric oncology unit.Diriba Fufa Hordofa, Muktar Ahmed, Zewdie Birhanu, Sheila Weitzman, Julie Broas
PLOS Global Public Health. 2024-01-01 - 1 citationsEthiopian paediatric oncology registry progress report: documentation practice improvements at tertiary care centre in Addis Ababa, Ethiopia.Scott Levy, Atalay Mulu Fentie, Kaitlyn M Buhlinger, Stephen M Clark, David N. Korones
Archives of Disease in Childhood. 2021-06-17 - 4 citationsResults of a pre-implementation analysis of Ethiopia's National Pediatric Cancer Registry.Kaitlyn M Buhlinger, Jared Borlagdan, Bemnat Agegnehu, Atalay Mulu Fentie, Adam T. Bernstein
Journal of Oncology Pharmacy Practice. 2020-12-20
Press Mentions
- Parents React After Pfizer Announces Its COVID-19 Vaccine Is Safe for Children Between the Ages of 5 to 11September 20th, 2021
- Samuelson Children’s HospitalOctober 18th, 2017